North America, the superdisintegrants market, is anticipated to reach US$ 248.18 Mn in 2027 from US$ 136.37 Mn in 2019. The market is projected to grow with a CAGR of 7.9% from 2020-2027.
The rise of the superdisintegrants market is driven by factors such as the increasing prevalence of neurological diseases and benefits offered by generic drugs are boosting the market over the years. Although, pricing pressure on drug manufacturers is likely to hinder the growth of the market in the future years.
The region is witnessing exponential growth in the prevalence of chronic diseases. Factors such as the progression of viruses, bacteria, parasites, coupled with the growing adoption of a sedentary lifestyle, genetic conditions, and consumption of poor diet, are responsible for the increasing prevalence of these diseases. Also, oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically include tablets, capsules, and powders for the treatment of particular disease conditions. Moreover, the growing emphasis on novel drug delivery approach is expected to boost awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients.
Furthermore, superdisintegrant tablets offer several benefits over traditional capsules and tablets. Advantages of disintegrants include an ability for accurate dosing, fast action, superior patient compliance, better palatability, and cost-effectiveness, as well as ease of administration, no risk of airway suffocation during swallowing, and flexibility in terms of large and small molecules. Such salient features of superdisintegrant tablets represent a massive potential for its adoption during tablet formulations. Thus, owing to the above-mentioned factors, the demand for superdisintegrants is increasing, which is anticipated to grow the market in the coming years.
In 2019, the US accounted for the largest market share in North America superdisintegrants market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country, and the country has the presence of various players that are well established in the pharmaceutical market. The companies are engaged in the research and development activities that are enabling them to develop the latest drugs for the diseases. Hence, considering the mentioned factors, the superdisintegrants market is expected to grow at a significant pace in the US during the forecast period.
US Superdisintegrants Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA COLORECTAL CANCER – MARKET SEGMENTATION
North America Colorectal Cancer Market - By Type
- Synthetic Superdisintegrants
- Crospovidone
- Modified Starch
- Modified Cellulose
- Calcium Silicates
- Ion Exchange Resins
- Natural Superdisintegrants
- Other Superdisintegrants
North America Colorectal Cancer Market - By Formulation
- Tablets
- Capsules
North America Colorectal Cancer Market - By Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Other Diseases
North America Colorectal Cancer Market - By Geography
North America
- US
- Canada
- Mexico
Company Profiles
- Ashland,
- BASF SE
- DowDupont Inc.
- JRS PHARMA
- COREL PHARMA CHEM
- Roquette Frères
- Asahi Kasei Corporation
- Merck KGaA
- Avantor, Inc.
- DFE Pharma
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Formulation, Therapeutic Area, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Superdisintegrants Market – By Type
1.3.2 North America Superdisintegrants Market – By Formulation
1.3.3 North America Superdisintegrants Market – By Therapeutic Area
1.3.4 North America Superdisintegrants Market – By Country
2. North America Superdisintegrants Market– Key Takeaways
2.1 Coverage
2.2 Secondary Research
2.3 Primary Research
3. North America Superdisintegrants Market – Market Landscape
3.1 Overview
3.2 PEST Analysis
3.2.1 Superdisintegrants Market - North America Pest Analysis
3.3 Expert Opinion
4. North America Superdisintegrants Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence Of Neurological Diseases
4.1.2 Increasing Acceptability of Generic Drugs
4.2 Key Restraints
4.2.1 Pricing Pressure On Drug Manufacturers
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Mexico
4.4 Future Trend
4.4.1 Inclination Towards Personalized Medicine
4.5 Impact Analysis
5. Superdisintegrants Market – North America Analysis
5.1 North America Superdisintegrants Market Revenue Forecasts and Analysis
5.2 Positioning Of Key Players
6. North America Superdisintegrants Market Analysis And Forecasts To 2027 – Type
6.1 Overview
6.2 North America Superdisintegrants Market, By Type 2019 & 2027 (%)
6.2.1 North America Superdisintegrants Market, Revenue And Forecast To 2027, By Type (US$ Mn)
6.2.1.1 North America Synthetic Superdisintegrants Market, Revenue And Forecast To 2027, By Type (US$ Mn)
6.3 Synthetic Superdisintegrants
6.3.1 Overview
6.3.2 North America Synthetic Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
6.3.2.1 Crospovidone Market
6.3.2.1.1 Overview
6.3.2.1.2 North America Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.2 Modified Starch Market
6.3.2.2.1 Overview
6.3.2.2.2 North America Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.3 Modified Cellulose Market
6.3.2.3.1 Overview
6.3.2.3.2 North America Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.4 Calcium Silicates Market
6.3.2.4.1 Overview
6.3.2.4.2 North America Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.5 Ion Exchange Resins Market
6.3.2.5.1 Overview
6.3.2.5.2 North America Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Natural Superdisintegrants
6.4.1 Overview
6.4.2 North America Natural Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
6.5 Other Superdisintegrants
6.5.1 Overview
6.5.2 North America Other Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
7. North America Superdisintegrants Market Analysis– By Formulation
7.1 Overview
7.2 North America Superdisintegrants Market, By Formulation 2019 & 2027 (%)
7.2.1 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
7.3 Tablets
7.3.1 Overview
7.3.2 North America Tablets Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Capsules
7.4.1 Overview
7.4.2 North America Capsules Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Superdisintegrants Market Analysis– By Therapeutic Area
8.1 Overview
8.2 North America Superdisintegrants Market, By Therapeutic Area 2019 & 2027 (%)
8.2.1 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
8.3 Neurological Diseases
8.3.1 Overview
8.3.2 North America Neurological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Gastrointestinal Diseases
8.4.1 Overview
8.4.2 North America Gastrointestinal Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Oncology
8.5.1 Overview
8.5.2 North America Oncology Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Inflammatory Diseases
8.6.1 Overview
8.6.2 North America Inflammatory Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Infectious Diseases
8.7.1 Overview
8.7.2 North America Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Cardiovascular Diseases
8.8.1 Overview
8.8.2 North America Cardiovascular Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Others
8.9.1 Overview
8.9.2 North America Others Market Revenue and Forecast to 2027 (US$ Mn)
9. Superdisintegrants Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 North America Superdisintegrants Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.3.1 North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.4 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.5 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.6 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
9.1.7 US
9.1.7.1 US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 US Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.2.1 US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.3 US Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.7.4 US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.8 Canada
9.1.8.1 Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.2.1 Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.3 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.8.4 Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.9 Mexico
9.1.9.1 Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.9.2 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.9.2.1 Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.9.3 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.9.4 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10. North America Superdisintegrants Market- Industry Landscape
10.1 Overview
11. Superdisintegrants Market–Key Company Profiles
11.1 Epigenomics AG
11.2 Ashland
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Asahi Kasei Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Avantor, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BASF SE
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Corel Pharma Chem
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Dow DuPont Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 DFE Pharma
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 JRS Pharma
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 MERCK KGAA
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Roquette Frères
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 3. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 4. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 5. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 6. North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 7. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 8. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 9. US Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 10. US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. US Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 12. US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 13. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 15. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 16. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 17. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 18. Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 19. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 20. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 21. Recent Organic Growth Strategies in the Superdisintegrants Market
Table 22. Glossary of Terms, Superdisintegrants Market
LIST OF FIGURES
Figure 1. Superdisintegrants Market Segmentation
Figure 2. North America Superdisintegrants Market Overview
Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Superdisintegrants Market
Figure 4. US Is Expected To Show Remarkable Growth During The Forecast Period
Figure 5. North America Superdisintegrants Market- Leading Country Markets (US$ Mn)
Figure 6. Research Methodology
Figure 7. Superdisintegrants Market - North America PEST Analysis
Figure 8. Superdisintegrants Market Impact Analysis of Drivers And Restraints
Figure 9. North America Superdisintegrants Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Market Positioning Of Key Player In North America Superdisintegrants Market
Figure 11. North America Superdisintegrants Market, by Type 2019 & 2027 (%)
Figure 12. North America Synthetic Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. North America Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
Figure 14. North America Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. North America Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
Figure 16. North America Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
Figure 17. North America Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. North America Natural Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. North America Other Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. North America Superdisintegrants Market, by Formulation 2019 & 2027 (%)
Figure 21. North America Tablets Market Revenue And Forecast To 2027 (US$ Mn)
Figure 22. North America Capsules Market Revenue And Forecast To 2027 (US$ Mn)
Figure 23. North America Superdisintegrants Market, by Therapeutic Area 2019 & 2027 (%)
Figure 24. North America Neurological Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 25. North America Gastrointestinal Market Revenue And Forecast To 2027 (US$ Mn)
Figure 26. North America Oncology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 27. North America Inflammatory Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 28. North America Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 29. North America Cardiovascular Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 30. North America Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 31. North America Superdisintegrants Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 32. North America Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 33. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 34. US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 35. Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 36. Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
The List of Companies - North America Superdisintegrants Market
- Ashland,
- BASF SE
- DowDupont Inc.
- JRS PHARMA
- COREL PHARMA CHEM
- Roquette Frères
- Asahi Kasei Corporation
- Merck KGaA
- Avantor, Inc.
- DFE Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Superdisintegrants Market
Feb 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)